Cargando…

Corrigendum to: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials

Detalles Bibliográficos
Autores principales: Golan, Yoav, DuPont, Herbert L, Aldomiro, Fernando, Jensen, Erin H, Hanson, Mary E, Dorr, Mary Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817080/
https://www.ncbi.nlm.nih.gov/pubmed/33511241
http://dx.doi.org/10.1093/ofid/ofaa629
_version_ 1783638571885789184
author Golan, Yoav
DuPont, Herbert L
Aldomiro, Fernando
Jensen, Erin H
Hanson, Mary E
Dorr, Mary Beth
author_facet Golan, Yoav
DuPont, Herbert L
Aldomiro, Fernando
Jensen, Erin H
Hanson, Mary E
Dorr, Mary Beth
author_sort Golan, Yoav
collection PubMed
description
format Online
Article
Text
id pubmed-7817080
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-78170802021-01-27 Corrigendum to: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials Golan, Yoav DuPont, Herbert L Aldomiro, Fernando Jensen, Erin H Hanson, Mary E Dorr, Mary Beth Open Forum Infect Dis Corrigendum Oxford University Press 2021-01-20 /pmc/articles/PMC7817080/ /pubmed/33511241 http://dx.doi.org/10.1093/ofid/ofaa629 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Golan, Yoav
DuPont, Herbert L
Aldomiro, Fernando
Jensen, Erin H
Hanson, Mary E
Dorr, Mary Beth
Corrigendum to: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials
title Corrigendum to: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials
title_full Corrigendum to: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials
title_fullStr Corrigendum to: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials
title_full_unstemmed Corrigendum to: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials
title_short Corrigendum to: Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials
title_sort corrigendum to: renal impairment, c. difficile recurrence, and the differential effect of bezlotoxumab: a post hoc analysis of pooled data from 2 randomized clinical trials
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817080/
https://www.ncbi.nlm.nih.gov/pubmed/33511241
http://dx.doi.org/10.1093/ofid/ofaa629
work_keys_str_mv AT golanyoav corrigendumtorenalimpairmentcdifficilerecurrenceandthedifferentialeffectofbezlotoxumabaposthocanalysisofpooleddatafrom2randomizedclinicaltrials
AT dupontherbertl corrigendumtorenalimpairmentcdifficilerecurrenceandthedifferentialeffectofbezlotoxumabaposthocanalysisofpooleddatafrom2randomizedclinicaltrials
AT aldomirofernando corrigendumtorenalimpairmentcdifficilerecurrenceandthedifferentialeffectofbezlotoxumabaposthocanalysisofpooleddatafrom2randomizedclinicaltrials
AT jensenerinh corrigendumtorenalimpairmentcdifficilerecurrenceandthedifferentialeffectofbezlotoxumabaposthocanalysisofpooleddatafrom2randomizedclinicaltrials
AT hansonmarye corrigendumtorenalimpairmentcdifficilerecurrenceandthedifferentialeffectofbezlotoxumabaposthocanalysisofpooleddatafrom2randomizedclinicaltrials
AT dorrmarybeth corrigendumtorenalimpairmentcdifficilerecurrenceandthedifferentialeffectofbezlotoxumabaposthocanalysisofpooleddatafrom2randomizedclinicaltrials